J Dig Cancer Res.  2023 Apr;11(1):41-44. 10.52927/jdcr.2023.11.1.41.

Proper Oral Hygiene and Dental Care for Cancer Patients

• Nam SJ

• KMID: 2541627
• DOI: http://doi.org/10.52927/jdcr.2023.11.1.41

Abstract

Oral complications, such as mucositis, infection, or xerostomia, are common in patients with cancer receiving chemotherapy or radiotherapy. These complications can cause pain, leading to increased consumption of analgesics, poor oral intake, malnutrition, and even a need for parenteral nutrition. Moreover, they can sometimes interrupt the treatment plan. This review focuses on the proper management and prevention of oral complications that are common in patients with cancer receiving chemotherapy or radiotherapy.

Keyword

Mucositis; Xerostomia; Oral hygiene; Chemotherapy; Radiotherapy

Reference

1. Mercadante S, Aielli F, Adile C, et al. 2015; Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Support Care Cancer. 23:3249–3255. https://doi.org/10.1007/s00520-015-2720-y. DOI: 10.1007/s00520-015-2720-y. PMID: 25832897.

2. Pulito C, Cristaudo A, Porta C, et al. 2020; Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res. 39:210. https://doi.org/10.1186/s13046-020-01715-7. DOI: 10.1186/s13046-020-01715-7. PMID: 33028357. PMCID: PMC7542970. PMID: 1119f70baff7442dbb19a9eac70fc95e.

3. Korean Society of Gastrointestinal Cancer Research. The Korean Society of Clinical Nutrition. 2013. Gastrointestinal nutritional oncology. Medbook;Seoul:

4. Keefe DM, Schubert MM, Elting LS, et al. 2007; Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 109:820–831. https://doi.org/10.1002/cncr.22484. DOI: 10.1002/cncr.22484. PMID: 17236223.

5. Peterson DE, Boers-Doets CB, Bensadoun RJ, Herrstedt J. ESMO Guidelines Committee. 2015; Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 26 Suppl 5:v139–v151. https://doi.org/10.1093/annonc/mdv202. DOI: 10.1093/annonc/mdv202. PMID: 26142468.

6. Mahood DJ, Dose AM, Loprinzi CL, et al. 199; Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol. 9:449–452. https://doi.org/10.1200/JCO.1991.9.3.449. DOI: 10.1200/JCO.1991.9.3.449. PMID: 1999715.

7. Cascinu S, Fedeli A, Fedeli SL, Catalano G. 1994; Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Eur J Cancer B Oral Oncol. 30B:234–236. https://doi.org/10.1016/0964-1955(94)90003-5. DOI: 10.1016/0964-1955(94)90003-5. PMID: 7950836.

8. Sorensen JB, Skovsgaard T, Bork E, Damstrup L, Ingeberg S. 2008; Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer. 112:1600–1606. https://doi.org/10.1002/cncr.23328. DOI: 10.1002/cncr.23328. PMID: 18300265.

9. Katrancı N, Ovayolu N, Ovayolu O, Sevinc A. 2012; Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy - a randomized controlled trial. Eur J Oncol Nurs. 16:339–344. https://doi.org/10.1016/j.ejon.2011.07.008. DOI: 10.1016/j.ejon.2011.07.008. PMID: 21911313.

10. Correa MEP, Cheng KKF, Chiang K, et al. 2020; Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 28:2449–2456. https://doi.org/10.1007/s00520-019-05217-x. DOI: 10.1007/s00520-019-05217-x. PMID: 31836937.

11. Riley P, Glenny AM, Worthington HV, Littlewood A, Clarkson JE, McCabe MG. 2015; Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy. Cochrane Database Syst Rev. 2015:CD011552. https://doi.org/10.1002/14651858.CD011552.pub2. DOI: 10.1002/14651858.CD011552.pub2. PMID: 26695736. PMCID: PMC8915172.

12. Rocke LK, Loprinzi CL, Lee JK, et al. 1993; A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer. 72:2234–2238. https://doi.org/10.1002/1097-0142(19931001)72:7<2234::aid-cncr2820720728>3.0.co;2-n. DOI: 10.1002/1097-0142(19931001)72:7<2234::AID-CNCR2820720728>3.0.CO;2-N. PMID: 8374882.

13. Spielberger R, Stiff P, Bensinger W, et al. 2004; Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 351:2590–2598. https://doi.org/10.1056/NEJMoa040125. DOI: 10.1056/NEJMoa040125. PMID: 15602019.

14. Hong CHL, Gueiros LA, Fulton JS, et al. 2019; Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 27:3949–3967. https://doi.org/10.1007/s00520-019-04848-4. DOI: 10.1007/s00520-019-04848-4. PMID: 31286232.

15. Vistoso Monreal A, Polonsky G, Shiboski C, Sankar V, Villa A. 2022; Salivary gland dysfunction secondary to cancer treatment. Front Oral Health. 3:907778. https://doi.org/10.3389/froh.2022.907778. DOI: 10.3389/froh.2022.907778. PMID: 35757443. PMCID: PMC9218178. PMID: 737429b9dd5649bbbd4ae35e1c32166c.

16. Pinna R, Campus G, Cumbo E, Mura I, Milia E. 2015; Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage. Ther Clin Risk Manag. 11:171–188. https://doi.org/10.2147/TCRM.S70652. DOI: 10.2147/TCRM.S70652. PMID: 25691810. PMCID: PMC4325830.

17. Lerman MA, Laudenbach J, Marty FM, Baden LR, Treister NS. 2008; Management of oral infections in cancer patients. Dent Clin North Am. 52:129–153. ixhttps://doi.org/10.1016/j.cden.2007.10.006. DOI: 10.1016/j.cden.2007.10.006. PMID: 18154868.